.
Discovery Experimental & Development Inc. (DEDI)
This website was written by:
James Kimball
Please Select A Category
DEDI also found out that no one in the world was able to develop Selegiline in a liquid form and stabilize the product for human use. Nor did it appear that anyone had been able to produce Selegiline HCL at or above 99% purity.
The fact was Selegiline HCL could only be produced by adding Hydrochloric Acid and making the product in pill form.
DEDI's Team Makes Miraculous Progress
After almost a year of working on the product Dr. Owen and Dr. Barltrop came up with Selegiline, without the use of Hydrochloric Acid in the form of a liquid and stabilized it, which again, had never been accomplished before. Not only had Dr. Owen come up with the perfect stabilizing agents; he had come up with every one of the stabilizing agents, being natural products. This in Kimball's mind made a world of difference. Now the product could be deemed a dietary supplement because all the ingredients within DEDI's product were either direct food products or their origin came from a plant. Not only that, Selegiline HCL which was in the FDA approved pills in combination, was not the same chemical as Selegiline liquid. DEDI named the product Liquid Deprenyl Citrate (LDC).
DEDI's President Kimball, immediately petitioned the FDA to deem the LDC a food supplement; food additive, or vitamin in mid-1991. The FDA immediately violated Kimball's 1st Amendment Rights of Petition, sent Kimball's petition back and refused to formally review the petition as required by law.
Selling Liquid Deprenyl Citrate
Kimball then formed a company in Tijuana, Mexico and began to sell the LDC to people all over the world. The LDC product was sold into the United States under a FDA exemption which stated in essence: any US citizen could import from a foreign country a 3 month supply of products without Government intervention.
DEDI had conferred with doctors and scientists all over the world prior to the sale of its LDC as to the amounts and side effects that may be forthcoming. Additionally, prior to LDC's introduction, doctors and scientists had been using LDC for nearly eight months. The benefits appeared outstanding while adverse side effects appeared to be non-existent as expected.
When LDC was finally offered for sale through Discovery in Mexico, in late 1991, a monitoring system was set up with doctors and individuals, to secure information as to how effective the product was, and if it had any adverse side effects that weren't taken into consideration.
Doctors reported the results, as did individual users, while forms were sent out to all purchasers to report whatever effects each one experienced using LDC.
DEDI knew, that they had developed and produced a product never developed before; which should be very effective with all kinds of neurological diseases. If the product worked the way it was designed to; it should have, at the least, dramatically improve the quality of life of the elderly.
LDC did far more that it was ever expected to do, as the reports came flooding in.
View how LDC worked and the results of doctors' trials and individual reports review How LDC Worked And Trial Results
An in dept accounting of the development of this product and others and what the Pharmaceutical Companies, FDA, and Florida Department of health did to stop Kimball; review Kimball’s affidavit written in 1994